
AI Errors May Be Impossible to Eliminate
Descrição
Regulatory Expectations from the U.S. Food and Drug Administration
Destaques
Explores the inevitability of AI errors and their implications in regulated industries. Discusses the probabilistic nature of AI systems and challenges in achieving error-free performance. Examines FDA expectations for AI-enabled tools in Good Manufacturing Practice (GMP) environments. Provides risk-based validation principles applicable to AI systems. Offers strategies for designing oversight mechanisms and human-in-the-loop safeguards. Identifies documentation requirements for AI governance. Establishes monitoring metrics for AI performance drift. Prepares defensible responses for regulatory inspections involving AI tools. Addresses data integrity considerations in AI applications. Discusses governance models for AI in regulated industries.
Diga à sua rede que vai participar
Partilhe este evento para iniciar conversas, convidar colegas e conectar-se antes que comece.